Equities researchers at StockNews.com started coverage on shares of SenesTech (NASDAQ:SNES – Get Free Report) in a report released on Monday. The firm set a “sell” rating on the stock.
Separately, HC Wainwright increased their price objective on shares of SenesTech from $3.50 to $10.00 and gave the stock a “buy” rating in a research report on Thursday, December 12th.
View Our Latest Analysis on SNES
SenesTech Trading Up 11.8 %
About SenesTech
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Featured Stories
- Five stocks we like better than SenesTech
- What is a Secondary Public Offering? What Investors Need to Know
- SAP’s Strong Momentum: A Bullish Setup for Investors
- Stock Average Calculator
- BlackRock Breaks Records: Why the Stock Still Has Room to Run
- What Are Dividend Champions? How to Invest in the Champions
- Duke vs. NRG: Which Energy Stock Will Power Higher Gains?
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.